Llwytho...
Targeting TFPI for hemophilia treatment
Hemophilia is a severe bleeding disorder treated by infusion of the missing blood coagulation protein, factor VIII or factor IX. The discovery and characterization of the anticoagulant protein tissue factor pathway inhibitor (TFPI) led to the realization that inhibition of TFPI activity could restor...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Thromb Res |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4950664/ https://ncbi.nlm.nih.gov/pubmed/27207418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0049-3848(16)30359-0 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|